Skip to main content

Table 6 Clinical characteristics of NAFLD patients and normal controls

From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation

Characteristics Cases (%) Controls (%) Z p value
ALT (IU/l) 27 (19–38) 19 (14–27) − 7.91 < 0.001
AST (IU/l) 23 (20–28) 20 (18–24) − 5.59 < 0.001
GLU (mmol/l) 5.34 (4.97–5.87) 5.19 (4.91–5.52) − 3.34 0.001
TC (mmol/l) 5.09 (4.49–5.65) 5.03 (4.56–5.45) − 0.94 0.35
TG (mmol/l) 1.77 (1.26–2.51) 1.18 (0.87–1.55) − 9.50 < 0.001
HDL (mmol/l) 3.13 (2.53–3.75) 3.19 (2.687–3.56) − 0.49 0.62
LDL (mmol/l) 1.21 (1.06–1.37) 1.35 (1.20–1.47) − 6.70 < 0.001
  1. Bold indicates that the analysis result is statistically significant
  2. AST serum aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltranspeptidase, FBG serum fasting glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein